As shown in our analyses, neuroendocrine markers and DLL3 are inversely correlated with inflamed SCLC tumors and may indicate the need for a different treatment approach, either independently or in combination with immunotherapy [47]. Here, DLL3 is linked to small cell lung carcinoma.